AI in Healthcare Summit Hong Kong

Tencent launched in 2017 the AI Medical Innovation System or AIMIS (觅影 miying in Chinese), an AI-powered diagnostic medical imaging technology. The internet giant has so far established AIMIS labs in over 10 hospitals across the country. They have also signed agreements to deploy AIMIS to close to 100 hospitals around China.

Procter & Gamble (P&G) has used proprietary artificial intelligence (AI) technology to create a Skin Advisor service for its Olay brand, a project that was two years in development.

Novel Drug Combinations Aim at Better Tuberculosis Therapy Outcomes- Scientists at UCLA and Shanghai Jiao Tong University say they have made an important step toward a substantially faster and more effective treatment for tuberculosis, which infects some 10 million people and causes 1.5 million deaths each year.

An international team of scientists led by the Hong Kong University of Science and Technology processed data from 1,918 HIV-infected patients globally to map the protein protrusions on the virus’ surface that predict how it mutates and its ability to replicate.

PET/CT provides a valuable tool for defining target tumour volumes and assessing therapy response. Its quantitative accuracy, however, is limited by respiratory-induced tumour motion. While respiratory gating can help compensate for such motion, its effectiveness varies greatly between individual patients.

Artificial Intelligence is rapidly transforming many conservative industries and is driving the fourth industrial revolution. Since Taiwan is the driver of innovation in Asia and took the leadership position during the computer and Internet booms. It is only natural for Taiwan to lead the fourth industrial revolution in health and longevity.